Larrieu, Pierre
320  results:
Search for persons X
?
2

Indoleamine 2,3-dioxygenase inhibitory activity of derivati..:

Dolušić, Eduard ; Larrieu, Pierre ; Meinguet, Céline...
Bioorganic & Medicinal Chemistry Letters.  23 (2013)  1 - p. 47-54 , 2013
 
?
3

Reversal of tumoral immune resistance by inhibition of tryp..:

Pilotte, Luc ; Larrieu, Pierre ; Stroobant, Vincent...
Proceedings of the National Academy of Sciences of the United States of America.  109 (2012)  7 - p. 2497-2502 , 2012
 
?
4

Reversal of tumoral immune resistance by inhibition of tryp..:

Pilotte, Luc ; Larrieu, Pierre ; Stroobant, Vincent...
Proceedings of the National Academy of Sciences.  109 (2012)  7 - p. 2497-2502 , 2012
 
?
 
?
6

Discovery and preliminary SARs of keto-indoles as novel ind..:

Dolušić, Eduard ; Larrieu, Pierre ; Blanc, Sébastien...
European Journal of Medicinal Chemistry.  46 (2011)  7 - p. 3058-3065 , 2011
 
?
 
?
10

Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors:

Röhrig, Ute F. ; Awad, Loay ; Grosdidier, Aurélien...
Journal of Medicinal Chemistry.  53 (2010)  3 - p. 1172-1189 , 2010
 
?
11

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by..:

Larrieu, Pierre ; Renaud, Virginie ; Godet, Yann..
Cancer Immunology, Immunotherapy.  57 (2007)  5 - p. 745-752 , 2007
 
?
 
?
14

L' origine préférentielle, critère déterminant du trait..:

, In: Revue trimestrielle de droit européen
Larrieu, Pierre-Jacques. (2021)  4 - p. 869-875
Copies:  Juridicum: z jur 100/875; Juridicum: z jur 100/875
 
1-15